Burgess Daniel D is a director of Cidara Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Arbutus Biopharma Corp
24 May 24
4
Cidara Therapeutics, Inc.
23 Jun 23
4
Arbutus Biopharma Corp
26 May 23
4
Nabriva Therapeutics plc
4 Aug 22
4
Cidara Therapeutics, Inc.
24 Jun 22
4
Arbutus Biopharma Corp
26 May 22
4
Nabriva Therapeutics plc
4 Aug 21
4
Nabriva Therapeutics plc
30 Jul 21
4
Cidara Therapeutics, Inc.
24 Jun 21
4
Arbutus Biopharma Corp
7 Jun 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
23 May 24 | ABUS Arbutus Biopharma | Stock Option Common Shares | Grant | Acquire A | No | No | 3.28 | 67,000 | 219.76 k | 67,000 |
22 Jun 23 | CDTX Cidara Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.17 | 42,500 | 49.73 k | 42,500 |
24 May 23 | ABUS Arbutus Biopharma | Stock Option Common Shares | Grant | Acquire A | No | No | 2.56 | 55,000 | 140.80 k | 55,000 |